跳至主要内容
临床试验/CTRI/2026/01/101240
CTRI/2026/01/101240尚未招募2 期

Effect of balaposhaka granules in the management of failure to thrive in children - an open label, single arm, interventional clinical study

J S Ayurveda Mahavidyalaya1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年2月1日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1

研究概览

简要总结

Failure to thrive is a common pediatric growth disorder characterized by inadequate weight gain in children, leading to long-term physical and developmental consequences if untreated. Ayurveda emphasizes the role of proper nutrition, digestion, and strength-promoting formulation in ensuring healthy growth during childhood. Balaposhaka granules is an ayurvedic formulation traditionally made to enhance digestion, nourishment, and immunity in children. This study is an open label, single arm interventional clinical trial planned to evaluate the effect of balaposhaka granules in children aged 2 to 8 years diagnosed with failure to thrive based on WHO weight fpr age standards. A total of  40 participants will receive age appropriate dose of balaposhaka granules orally twice daily with milk for a duration of 4 weeks. The primary outcome measure is improvement in weight for age, while secondary outcomes include assessment of general health parameters such as appetite, activity level, sleep, bowel habits and overall well being. The study aims to assess the efficacy and safety of balaposhaka granules in the management of failure to thrive in children

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
2.00 Year(s) 至 8.00 Year(s)(—)
性别
All

入选标准

  • 1 Children belonging to age group 2 to 8 years irrespective of religion, gender and socio-economic status.
  • 2 Children diagnosed with Failure to thrive below 3rd and 5th percentile of weight-for- age according to WHO growth chart.
  • 3 Children with normal cognitive milestone for age to ensure proper feeding and compliance.
  • Children who are medically stable with no acute illness at the time of enrollment.

排除标准

  • 1 Age below 2 years and above 8 years.
  • 2 Children whose weight is above 5th percentile based on weight-for-age according to WHO growth chart.
  • 3 Children having systemic, neurological, endocrinal, genetic disorders, congenital anomalies and anatomical defects.

研究者

发起方
J S Ayurveda Mahavidyalaya
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Dipali Rakeshbhai Agrawal

J S Ayurveda Mahavidyalaya and P D Patel Ayurveda Hospital

研究点 (1)

Loading locations...

相似试验